Received Sep 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | 946062 | IM / LA |
No adverse event. Reporting because unnecessary vaccine was given. Pt had already received and completed the hep a/hep b series in 2019, so this dose of heplisav was not indicated.
none
propoxyphene
not applicable.